Accelerating Innovation by combining 3D Printing and Solubility Enhancement

As the pharmaceutical industry embraces advanced manufacturing, the fusion of 3D printing and mesoporous silica loading presents a transformative opportunity for tackling solubility challenges in drug development. This session, led by experts from Merck KGaA (Darmstadt, Germany) and Aprecia Pharmaceuticals, explores how Parteck® SLC—a high-surface-area silica—can be combined with additive manufacturing to enhance bioavailability, streamline formulation, and accelerate clinical timelines. Attendees will gain insights into Aprecia’s binder jetting technologies using SoluPrint™ with in-blister tablet printing platforms. Real-world case studies demonstrate the potential for personalized, scalable, and GMP-compliant production. Join us to discover how these synergistic technologies are reshaping the future of oral dosage forms.